| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Research Communications |
a Human Genome Sciences, Inc., Rockville, Maryland 20850, USA
b Cytokine Research Laboratory, Department of Molecular Oncology, the University of Texas, M.D. Anderson Cancer, Houston, Texas 77030, USA
c Georgetown University Medical Center, Lombardi Cancer Center, Washington, D.C. 20007, USA
A novel member of the tumor necrosis factor (TNF) family has been identified from the human umbilical vein endothelial cell cDNA library, named vascular endothelial growth inhibitor (VEGI). The VEGI gene was mapped to human chromosome 9q32. The cDNA for VEGI encodes a protein of 174 amino acid residues with the characteristics of a type II transmembrane protein. Its amino acid sequence is 20–30% identical to other members of the TNF family. Unlike other members of the TNF family, VEGI is expressed predominantly in endothelial cells. Local production of a secreted form of VEGI via gene transfer caused complete suppression of the growth of MC-38 murine colon cancers in syngeneic C57BL/6 mice. Histological examination showed marked reduction of vascularization in MC-38 tumors that expressed soluble but not membrane-bound VEGI or were transfected with control vector. The conditioned media from soluble VEGI-expressing cells showed marked inhibitory effect on in vitro proliferation of adult bovine aortic endothelial cells. Our data suggest that VEGI is a novel angiogenesis inhibitor of the TNF family and functions in part by directly inhibiting endothelial cell proliferation. The results further suggest that VEGI maybe highly valuable toward angiogenesis-based cancer therapy.—Zhai, Y., Ni, J., Jiang, G.-W., Lu, J., Xing, L., Lincoln, C., Carter, K. C., Janat, F., Kozak, D., Xu, S., Rojas, L., Aggarwal, B. B., Ruben, S., Li, L.-Y., Gentz, R., Yu, G.-L. VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo. FASEB J. 13, 181–189 (1999)
Key Words: TNF • cytokine • anti-tumor • anti-angiogenesis • EST
This article has been cited by other articles:
|
|
 |
|
  B. P. Pappu, A. Borodovsky, T. S. Zheng, X. Yang, P. Wu, X. Dong, S. Weng, B. Browning, M. L. Scott, L. Ma, et al. TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease J. Exp. Med., May 12, 2008; 205(5): 1049 - 1062. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Tian, S. Grimaldo, M. Fugita, J. Cutts, N. L. Vujanovic, and L.-Y. Li The Endothelial Cell-Produced Antiangiogenic Cytokine Vascular Endothelial Growth Inhibitor Induces Dendritic Cell Maturation J. Immunol., September 15, 2007; 179(6): 3742 - 3751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Sato and H. Sonoda The Vasohibin Family: A Negative Regulatory System of Angiogenesis Genetically Programmed in Endothelial Cells Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 37 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Xu, Y. Yu, and E. J. Duh Vascular Endothelial Growth Factor Upregulates Expression of ADAMTS1 in Endothelial Cells through Protein Kinase C Signaling. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 4059 - 4066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-Y. Kim, K.-M. Toellner, A. White, F. M. McConnell, F. M. C. Gaspal, S. M. Parnell, E. Jenkinson, G. Anderson, and P. J. L. Lane Neonatal and Adult CD4+CD3- Cells Share Similar Gene Expression Profile, and Neonatal Cells Up-Regulate OX40 Ligand in Response to TL1A (TNFSF15). J. Immunol., September 1, 2006; 177(5): 3074 - 3081. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. N. Kloth, G. J. Fleuren, J. Oosting, R. X. de Menezes, P. H.C. Eilers, G. G. Kenter, and A. Gorter Substantial changes in gene expression of Wnt, MAPK and TNF{alpha} pathways induced by TGF-{beta}1 in cervical cancer cell lines Carcinogenesis, September 1, 2005; 26(9): 1493 - 1502. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Hou, D. Medynski, S. Wu, X. Lin, and L.-Y. Li VEGI-192, a New Isoform of TNFSF15, Specifically Eliminates Tumor Vascular Endothelial Cells and Suppresses Tumor Growth Clin. Cancer Res., August 1, 2005; 11(15): 5595 - 5602. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Oshima, K. Sato, F. Tashiro, J.-i. Miyazaki, K. Nishida, Y. Hiraki, Y. Tano, and C. Shukunami Anti-angiogenic action of the C-terminal domain of tenomodulin that shares homology with chondromodulin-I J. Cell Sci., June 1, 2004; 117(13): 2731 - 2744. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Matsui, Y. Hikichi, I. Tsuji, T. Yamada, and Y. Shintani LIGHT, a Member of the Tumor Necrosis Factor Ligand Superfamily, Prevents Tumor Necrosis Factor-alpha -mediated Human Primary Hepatocyte Apoptosis, but Not Fas-mediated Apoptosis J. Biol. Chem., December 13, 2002; 277(51): 50054 - 50061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E S Bamberger and C W Perrett Angiogenesis in epithelian ovarian cancer Mol. Pathol., December 1, 2002; 55(6): 348 - 359. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Hayakawa, K. Takeda, H. Yagita, M. J. Smyth, L. Van Kaer, K. Okumura, and I. Saiki IFN-gamma -mediated inhibition of tumor angiogenesis by natural killer T-cell ligand, alpha -galactosylceramide Blood, August 13, 2002; 100(5): 1728 - 1733. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L. Bale, F. J. Giordano, R. P. Hickey, Y. Huang, A. K. Nath, K. L. Peterson, W. W. Vale, and K.-F. Lee Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization PNAS, May 28, 2002; 99(11): 7734 - 7739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jakubowski, B. Browning, M. Lukashev, I. Sizing, J. S. Thompson, C. D. Benjamin, Y.-M. Hsu, C. Ambrose, T. S. Zheng, and L. C. Burkly Dual role for TWEAK in angiogenic regulation J. Cell Sci., January 15, 2002; 115(2): 267 - 274. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Kerbel Tumor angiogenesis: past, present and the near future Carcinogenesis, March 1, 2000; 21(3): 505 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Yu, S. Tian, L. Metheny-Barlow, L.-J. Chew, A. J. Hayes, H. Pan, G.-L. Yu, and L.-Y. Li Modulation of Endothelial Cell Growth Arrest and Apoptosis by Vascular Endothelial Growth Inhibitor Circ. Res., December 7, 2001; 89(12): 1161 - 1167. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
